Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • small interfering RNARemove small interfering RNA filter
    Clear all

    Article Type

    • Research Article12

    Publication Date

    Author

    • Gao, Tianwen2
    • Li, Chunying2
    • Abraham, Brian J1
    • An, Yawen1
    • Bernerd, Françoise1
    • Bhogal, Ranjit K1
    • Bíró, Tamás1
    • Chang, Yuqian1
    • Chen1
    • Chen, Jie Zhong1
    • Chen, Wan-Rung1
    • Cheng, Chao-Min1
    • Chignon-Sicard, Bérengère1
    • Christensen, Camilla L1
    • Croft, Amanda1
    • Cui, Tingting1
    • Dai, Wei1
    • Debayle, Delphine1
    • Dinger, Marcel E1
    • Eliades, Philip1
    • Fan, Yu-Ching1
    • Farjo, Bessam1
    • Farjo, Nilofer1
    • Farrelly, Margaret1
    • Furuta, Junpei1

    Journal

    • Journal of Investigative Dermatology12

    Keyword

    • siRNA12
    • extracellular signal-regulated kinase4
    • shRNA4
    • ERK3
    • reactive oxygen species3
    • ROS3
    • MAPK2
    • mitogen-activated protein kinase2
    • Nrf22
    • qRT-PCR2
    • 3,4-dihydro-5-[4-(1-piperidinyl) butoxy]-1(2H)-isoquinolinone1
    • 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide1
    • 5-fluorouracil1
    • 5-Fu1
    • 8-oxo-deoxy-guanine1
    • 8-oxo-dGTP1
    • AFM1
    • AREG1
    • CAT1
    • CDK1
    • ChIP-seq1
    • COL1
    • CTD1
    • CTLs1

    Access Filter

    • Open Access

    Melanoma

    12 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Original Article Melanocytes/Melanoma
      Open Archive

      High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma

      Journal of Investigative Dermatology
      Vol. 138Issue 7p1582–1590Published online: February 2, 2018
      • Philip Eliades
      • Brian J. Abraham
      • Zhenyu Ji
      • David M. Miller
      • Camilla L. Christensen
      • Nicholas Kwiatkowski
      • and others
      Cited in Scopus: 33
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Cutaneous melanoma is an aggressive tumor that accounts for most skin cancer deaths. Among the physiological barriers against therapeutic success is a strong survival program driven by genes such as MITF that specify melanocyte identity, a phenomenon known in melanoma biology as lineage dependency. MITF overexpression is occasionally explained by gene amplification, but here we show that super-enhancers are also important determinants of MITF overexpression in some melanoma cell lines and tumors.
        High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma
      • Original Article Wound Healing
        Open Archive

        Caveolin-1 Controls Hyperresponsiveness to Mechanical Stimuli and Fibrogenesis-Associated RUNX2 Activation in Keloid Fibroblasts

        Journal of Investigative Dermatology
        Vol. 138Issue 1p208–218Published online: September 9, 2017
        • Chao-Kai Hsu
        • Hsi-Hui Lin
        • Hans I Harn
        • Rei Ogawa
        • Yang-Kao Wang
        • Yen-Ting Ho
        • and others
        Cited in Scopus: 55
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Keloids are pathological scars characterized by excessive extracellular matrix production that are prone to form in body sites with increased skin tension. CAV1, the principal coat protein of caveolae, has been associated with the regulation of cell mechanics, including cell softening and loss of stiffness sensing ability in NIH3T3 fibroblasts. Although CAV1 is present in low amounts in keloid fibroblasts (KFs), the causal association between CAV1 down-regulation and its aberrant responses to mechanical stimuli remain unclear.
          Caveolin-1 Controls Hyperresponsiveness to Mechanical Stimuli and Fibrogenesis-Associated RUNX2 Activation in Keloid Fibroblasts
        • Original Article Melanocytes/Melanoma
          Open Access

          Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3

          Journal of Investigative Dermatology
          Vol. 138Issue 1p171–178Published online: August 22, 2017
          • Claire Regazzetti
          • Laura Sormani
          • Delphine Debayle
          • Françoise Bernerd
          • Meri K. Tulic
          • Gian Marco De Donatis
          • and others
          Cited in Scopus: 174
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            The shorter wavelengths of the visible light spectrum have been recently reported to induce a long-lasting hyperpigmentation but only in melano-competent individuals. Here, we provide evidence showing that OPN3 is the key sensor in melanocytes responsible for hyperpigmentation induced by the shorter wavelengths of visible light. The melanogenesis induced through OPN3 is calcium dependent and further activates CAMKII followed by CREB, extracellular signal-regulated kinase, and p38, leading to the phosphorylation of MITF and ultimately to the increase of the melanogenesis enzymes: tyrosinase and dopachrome tautomerase.
            Melanocytes Sense Blue Light and Regulate Pigmentation through Opsin-3
          • Original Article Immunology/Infection
            Open Archive

            STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways

            Journal of Investigative Dermatology
            Vol. 137Issue 10p2101–2109Published online: June 21, 2017
            • Ji-Ae Kim
            • Seul-Ki Park
            • Seong-Wook Seo
            • Chan-Hee Lee
            • Ok Sarah Shin
            Cited in Scopus: 36
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Varicella zoster virus (VZV) is a human-restricted α-herpesvirus that exhibits tropism for the skin. The VZV host receptors and downstream signaling pathways responsible for the antiviral innate immune response in the skin are not completely understood. Here, we show that STING mediates an important host defense against VZV infection in dermal cells including human dermal fibroblasts and HaCaT keratinocytes. Inhibition of STING using small interfering-RNA or short hairpin RNA-mediated gene disruption resulted in enhanced viral replication but diminished IRF3 phosphorylation and induction of IFNs and proinflammatory cytokines.
              STING Is Involved in Antiviral Immune Response against VZV Infection via the Induction of Type I and III IFN Pathways
            • Original Article Melanocytes/Melanoma
              Open Archive

              Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2

              Journal of Investigative Dermatology
              Vol. 137Issue 6p1286–1296Published online: February 4, 2017
              • Yuqian Chang
              • Shuli Li
              • Weinan Guo
              • Yuqi Yang
              • Weigang Zhang
              • Qian Zhang
              • and others
              Cited in Scopus: 43
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                The prevention of hydrogen peroxide (H2O2)-induced oxidative stress has proved to be beneficial to vitiligo patients. Simvastatin possesses antioxidative capacity and has shown protective effect in various oxidative stress-related diseases. However, whether simvastatin can protect human melanocytes against oxidative stress has not been investigated. In this study, we initially found that pretreatment with 0.1 μmol/L to 1.0 μmol/L simvastatin led to increased cell viability and decreased cell apoptosis of melanocytes in response to H2O2.
                Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2
              • Original Article Appendages
                Open Archive

                Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition

                Journal of Investigative Dermatology
                Vol. 137Issue 2p295–304Published online: October 1, 2016
                • Iain S. Haslam
                • Laura Jadkauskaite
                • Imre Lőrinc Szabó
                • Selma Staege
                • Jasper Hesebeck-Brinckmann
                • Gail Jenkins
                • and others
                Cited in Scopus: 45
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  The in situ control of redox insult in human organs is of major clinical relevance, yet remains incompletely understood. Activation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the “master regulator” of genes controlling cellular redox homeostasis, is advocated as a therapeutic strategy for diseases with severely impaired redox balance. It remains to be shown whether this strategy is effective in human organs, rather than only in isolated human cell types. We have therefore explored the role of Nrf2 in a uniquely accessible human (mini-) organ: scalp hair follicles.
                  Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition
                • Original Article Melanocytes/Melanoma
                  Open Access

                  Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588

                  Journal of Investigative Dermatology
                  Vol. 136Issue 11p2277–2286Published online: July 14, 2016
                  • Jia Yu Wang
                  • Lei Jin
                  • Xu Guang Yan
                  • Simonne Sherwin
                  • Margaret Farrelly
                  • Yuan Yuan Zhang
                  • and others
                  Cited in Scopus: 31
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    The effect of MTH1 inhibition on cancer cell survival has been elusive. Here we report that although silencing of MTH1 does not affect survival of melanoma cells, TH588, one of the first-in-class MTH1 inhibitors, kills melanoma cells through apoptosis independently of its inhibitory effect on MTH1. Induction of apoptosis by TH588 was not alleviated by MTH1 overexpression or introduction of the bacterial homolog of MTH1 that has 8-oxodGTPase activity but cannot be inhibited by TH588, indicating that MTH1 inhibition is not the cause of TH588-induced killing of melanoma cells.
                    Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588
                  • Original Article Tumor Biology
                    Open Archive

                    Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS

                    Journal of Investigative Dermatology
                    Vol. 136Issue 6p1267–1277Published online: February 20, 2016
                    • Jinjing Jia
                    • Changji Li
                    • Suju Luo
                    • Feng Liu-Smith
                    • Jiao Yang
                    • Xin Wang
                    • and others
                    Cited in Scopus: 34
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      Cutaneous squamous cell carcinoma (cSCC) is one of the most common skin malignant tumors with an increasing incidence. Studies have shown that Yes-associated protein (YAP) participates in the development of a variety of tumors as an oncogene, but to our knowledge its role in cSCC has not been reported. In this study, we used immunohistochemistry to show that YAP expression was elevated in cSCC samples of different stages versus in normal skin and that it was well correlated with the progression of the disease.
                      Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS
                    • Original Article Melanocytes/Melanoma
                      Open Archive

                      Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1

                      Journal of Investigative Dermatology
                      Vol. 136Issue 6p1219–1228Published online: February 12, 2016
                      • Rui Ge
                      • Lin Liu
                      • Wei Dai
                      • Weigang Zhang
                      • Yuqi Yang
                      • Huina Wang
                      • and others
                      Cited in Scopus: 25
                      • Preview Hide Preview
                      • Download PDF
                      • Export Citation
                        Xeroderma pigmentosum group A (XPA), a key protein in the nucleotide excision repair pathway, has been shown to promote the resistance of tumor cells to chemotherapeutic drugs by facilitating the DNA repair process. However, the role of XPA in the resistance of melanoma to platinum-based drugs like cisplatin is largely unknown. In this study, we initially found that XPA was expressed at higher levels in cisplatin-resistant melanoma cells than in cisplatin-sensitive ones. Furthermore, the knockdown of XPA not only increased cellular apoptosis but also inhibited cisplatin-induced autophagy, which rendered the melanoma cells more sensitive to cisplatin.
                        Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1
                      • Original Article Melanocytes/Melanoma
                        Open Archive

                        The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes

                        Journal of Investigative Dermatology
                        Vol. 136Issue 4p819–828Published online: January 29, 2016
                        • Wei Zhao
                        • Joseph Mazar
                        • Bongyong Lee
                        • Junko Sawada
                        • Jian-Liang Li
                        • John Shelley
                        • and others
                        Cited in Scopus: 31
                        • Preview Hide Preview
                        • Download PDF
                        • Export Citation
                          The long noncoding RNA SPRIGHTLY (formerly SPRY4-IT1), which lies within the intronic region of the SPRY4 gene, is up-regulated in human melanoma cells compared to melanocytes. SPRIGHTLY regulates a number of cancer hallmarks, including proliferation, motility, and apoptosis. To better understand its oncogenic role, SPRIGHTLY was stably transfected into human melanocytes, which resulted in increased cellular proliferation, colony formation, invasion, and development of a multinucleated dendritic-like phenotype.
                          The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes
                        • Original Article Keratinocytes/Epidermis
                          Open Access

                          Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation

                          Journal of Investigative Dermatology
                          Vol. 136Issue 1p192–201Published in issue: January, 2016
                          • Nan-Lin Wu
                          • Duen-Yi Huang
                          • Li-Fang Wang
                          • Reiji Kannagi
                          • Yu-Ching Fan
                          • Wan-Wan Lin
                          Cited in Scopus: 23
                          • Preview Hide Preview
                          • Download PDF
                          • Export Citation
                            Spleen tyrosine kinase (Syk), a nonreceptor tyrosine kinase, was initially identified as a crucial regulator in proximal immunoreceptor signaling. Additional studies have revealed its pleiotropic roles, and drugs targeting Syk are under development for inflammatory diseases. Syk expression in the skin has been detected, but its functions in the skin are still unknown. Here, we found that Syk phosphorylation and expression in primary human keratinocytes decreased gradually along with terminal differentiation.
                            Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation
                          • Original Article Melanocytes/Melanoma
                            Open Archive

                            Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase

                            Journal of Investigative Dermatology
                            Vol. 136Issue 1p255–263Published in issue: January, 2016
                            • Takashi Inozume
                            • Tomonori Yaguchi
                            • Junpei Furuta
                            • Kazutoshi Harada
                            • Yutaka Kawakami
                            • Shinji Shimada
                            Cited in Scopus: 110
                            • Preview Hide Preview
                            • Download PDF
                            • Export Citation
                              Recently, T-cell immunoreceptor with Ig and ITIM domains (TIGIT) was reported as a candidate for novel immune checkpoints. However, the impact of TIGIT on melanoma-specific cytotoxic T lymphocytes in the effector phase remains unclear. In this study, we demonstrated that melanoma cells control antimelanoma cytotoxic T lymphocyte responses via the TIGIT-CD155 interaction in the effector phase. TIGIT is an inhibitory receptor expressed on T cells, and CD155 is one of the cognate ligands expressed on the tumor cells or antigen-presenting cells.
                              Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase
                            Page 1 of 1

                            Login to your account

                            Show
                            Forgot password?
                            Don’t have an account?
                            Create a Free Account

                            If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                            If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                            Cancel
                            • Home
                            • Articles & Issues
                            • Articles In Press
                            • Current Issue
                            • List of Issues
                            • Meeting Abstracts
                            • Supplements
                            • Authors
                            • About Open Access
                            • Submit a Manuscript
                            • Welcome, Authors!
                            • Information for Authors
                            • Information for Authors - PDF Download
                            • Contact
                            • Permissions
                            • Reviewers
                            • Information for Reviewers
                            • Reviewer Login
                            • Journal Info
                            • About the Journal
                            • About Open Access
                            • Contact the Editorial Office
                            • Editorial Board
                            • Abstracting/Indexing
                            • Access Instructions
                            • New Content Alerts
                            • Submit a Manuscript
                            • Why Publish in JID?
                            • Collections
                            • Atopic Dermatitis
                            • Cover Gallery
                            • Itch
                            • JAAD / JID Junction
                            • Landmarks in Cutaneous Biology
                            • Melanoma
                            • Methods and Techniques for Skin Research
                            • Montagna Symposium on the Biology of Skin
                            • Pemphigus & Pemphigoid
                            • Progress in Translational Research
                            • Psoriasis
                            • Resources for Clinical Research in the JID
                            • News
                            • Society/Journal News
                            • Advertisers
                            • SID
                            • SID Member Activation
                            • SID Website
                            • Join SID
                            • Annual Meeting
                            • Academic Industry Partnership
                            • ESDR
                            • ESDR Website
                            • Join ESDR
                            • Awards
                            • Events
                            • Media
                            • Education
                            • JAAD / JID Junction - NEW!
                            • Companion Titles
                            • Journal of Investigative Dermatology Symposium Proceedings
                            • JID Innovations
                            • Follow Us
                            • Facebook
                            • Twitter

                            The content on this site is intended for healthcare professionals.



                            We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                            Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                            • Privacy Policy  
                            • Terms and Conditions  
                            • Accessibility  
                            • Help & Contact

                            RELX